BNET Industries

Oxis International Inc.

(OXIS) is in the Pharma Industry

Market Cap:$11.0M
Last Fiscal Year Sales:$6.0M
  • Public
  • US
Dow Jones Description

Not stressing over their therapies. Founded in 1965 and headquartered in Portland, OR, OXIS International, Inc. (NASDAQ: OXIS) is a provider of diagnosis and treatment services for oxidative stress-related diseases. Diagnostic assays and drug monitoring assays produced by its subsidiary, OXIS Health Products, make up the bulk of its sales. Its BXT-51072 product is currently undergoing trials, and is likely to treat inflammatory bowel disease. The company employs about 11 people and it had 2006 revenue of about $2.4 million. In February 2006, it moved key administrative functions to its U.S. FDA certified cGMP device manufacturing facility in Foster City, CA.

Number of Employees 5
Contact Information

468 N. Camden Dr 2nd Fl

Beverly Hills, California 90210

www.oxis.com

(310) 860-5184

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

finance and oxis international inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Steven T. Guillen Oxis CEO
Michael D. Centron CFO & Vice President
Sharon Ellis COO
Ray Jacobs Vice President, Marketing, sales
Bruce Hoffman Director, Health
Randall Moeckli Senior Director, Sales, Marketing
Sarah Hathaway Manager, Regulatory Affairs
Anna Gralinska
S. Colin Neill Secretary
Richard A Davis Director
Stuart S Lang Director
Timothy G Biro Director

Board of Directors

Name (plus bio) Position
Joseph F Bozman Jr Chairman of the Board
Gary M. Post Board of Directors
John E. Repine Board of Directors
Timothy C. Rodell Board of Directors

OXIS International will continue its innovation in the biomarker research space under the direction of CEO, Steve Guillen. Steve offers an extensive background in building highly successful commercial organizations in the diagnostic and pharmaceutical industries, including senior executive management positions at Amarin Pharmaceuticals, Elan Pharmaceuticals, Athena Diagnostics, and Athena Neurosciences. With Steve's experience, OXIS International is more committed than ever to developing new research assays designed to help researchers advance the understanding of diseases.

Organization Position Status
Oxis International, Inc. Oxis CEO Current
Oxis Health Products, Inc. Board of Directors Current
Oxis International, Inc. Board of Directors Current
Athena Diagnostics, Inc. Vice President, Sales and Marketing Former
Athena Diagnostics, Inc. Senior Executive Former
Elan Pharmaceuticals, Inc. Senior Executive Former
Elan Corporation, PLC Former
Merck & Co. Inc. Former
University of California, Davis B.S. In Zoology Former

Organization Position Status
Oxis International, Inc. CFO & Vice President Current

Organization Position Status
Oxis International, Inc. COO Current

Organization Position Status
Oxis International, Inc. Vice President, Marketing, sales Current

Organization Position Status
Oxis International, Inc. Director, Health Current

Organization Position Status
Oxis International, Inc. Senior Director, Sales, Marketing Current

Organization Position Status
Oxis International, Inc. Manager, Regulatory Affairs Current

Organization Position Status
Lyonshare Vice President Current
Oxis International, Inc. Current
Avis Budget Group, Inc. Director of Investor Relations Former
Wesleyan University Bachelor of Arts Degree Former

S. Colin Neill who becomes President of the Company, became Senior Vice President, Chief Financial Officer, Secretary and Treasurer of Pharmos in October 2006. From September 2003 to October 2006, Mr. Neill served as Chief Financial Officer, Treasurer and Secretary of Axonyx, Inc. a biopharmaceutical company that developed products and technologies to treat Alzheimer's disease and other central nervous system disorders, where he played an integral role in the merger between Axonyx and TorreyPines Therapeutics Inc., a privately-held biopharmaceutical company. From 1998 to 2001, Mr. Neill served as Senior Vice President, Chief Financial Officer, Secretary and Treasurer of ClinTrials Research Inc., a $100 million publicly traded global contract research organization in the drug development business. Mr. Neill played a key role in the successful sale of the company in 2001. Mr. Neill graduated from Trinity College, Dublin with a first class honors degree in Business / Economics and he holds a masters degree in Accounting and Finance from the London School of Economics. He is a Certified Public Accountant in New York State and a Chartered Accountant in Ireland.

Organization Position Status
Pharmos Corporation President, Cfo, Secretary and Treasurer Current
Axonyx Inc. CFO, Treasurer & Secretary Current
Oxis Health Products, Inc. Secretary and Director Current
Oxis International, Inc. Secretary Current
Oxis Health Products, Inc. Chairman Current
Oxis International, Inc. Board of Directors Current
Oxis Health Products, Inc. Director Current
Pharmos Corporation Treasurer Current
Axonyx Inc. Board of Directors Current
BTR Incorporated Chief Financial Officer Former
Pharmos Corporation Senior Vice President Former
BTR Incorporated Vice President Finance Former
The London School of Economics Masters Degree In Accounting and Finance Former
Trinity College Degree In Business, Economics Former

Organization Position Status
Oxis International, Inc. Chairman of the Board Current

Organization Position Status
Oxis International, Inc. Board of Directors Current

Organization Position Status
Oxis International, Inc. Board of Directors Current

Organization Position Status
Oxis International, Inc. Director Current

Organization Position Status
Oxis International, Inc. Director Current

Organization Position Status
GlobeImmune Inc. President & Chief Executive Officer Current
Barofold, Inc Founder Current
Oxis Health Products, Inc. Current
Oxis International, Inc. Board of Directors Current
Oxis International, Inc. Director Current
GlobeImmune Inc. Board of Directors Current
American College of Chest Physicians Fellow Current
Rx Kinetix, Inc. Chief Executive Officer Former
Rx Kinetix, Inc. President Former
Oxis International, Inc. President Former
Oxis International, Inc. Chief Technology Officer Former
Kent International Holdings Inc Executive Vice President of Operations and Product Development Former
MTR Corporation Limited Managing Partner Former
University of North Carolina School of Medicine M.D. Former

Organization Position Status
Oxis International, Inc. Director Current
advertisement
Click Here
     OXIS $0.23 -0.01 (-4.08% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 205,407
Shares Outstanding 47.00M
Market Cap 11.0M
Year High 0.61
Year Low 0.031
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Click Here